Biogen Names Michel Vounatsos as New CEO

Prominent biotech company Biogen (NASDAQ: BIIB) has picked a new CEO from among its executive ranks. Michel Vounatsos, who currently serves as its chief commercial officer, will formally take up the position on Jan. 6, replacing George Scangos. Earlier this year, Scangos, who has been Biogen’s CEO since 2010, announced his intention to step down from the post once a successor was appointed. Vounatsos has not been at the company long. …read more

Read more here: Biogen Names Michel Vounatsos as New CEO

Category: BIIB

Leave a Reply

%d bloggers like this: